down arrow

Pfizer

28
Strong Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,053.50
21.55 (0.53%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 10.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Pfizer Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Nov'08
Nov'07
No of Months
12
12
Profit Before Tax
211.22
468.69
Adjustment
-49.50
-298.39
Changes In working Capital
-7.89
-33.38
Cash Flow after changes in Working Capital
153.82
136.91
Cash Flow from Operating Activities
237.76
16.63
Cash Flow from Investing Activities
-78.87
232.34
Cash Flow from Financing Activities
-95.19
-75.89
Net Cash Inflow / Outflow
63.69
173.08
Opening Cash & Cash Equivalents
479.91
306.82
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
Closing Cash & Cash Equivalent
543.60
479.91
Compare Cash Flow Results of Pfizer
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
21122.06
2399.36
18,723.00
780.32%
Adjustment
-4950
212.2
-5,162.00
-2432.70%
Changes In working Capital
-789.18
20.42
-809.00
-3964.74%
Cash Flow after changes in Working Capital
15382.88
2631.98
12,751.00
484.46%
Cash Flow from Operating Activities
23776.26
2152.45
21,624.00
1004.61%
Cash Flow from Investing Activities
-7887.35
-2080.52
-5,807.00
-279.10%
Cash Flow from Financing Activities
-9519.58
5.27
-9,524.00
-180737.19%
Net Cash Inflow / Outflow
6369.33
77.19
6,292.00
8151.50%
Opening Cash & Cash Equivalents
47991.26
304.82
47,687.00
15644.13%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
54360.59
382.01
53,978.00
14130.15%
Cash Flow - Snapshot (Standalone) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is -27.79% vs -46.68% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
256.84
355.68
-27.79%